India is launching a major initiative to boost its biopharmaceutical manufacturing. This plan aims to reduce reliance on China for crucial ...

Eli Lilly India chief Winselow Tucker said the company’s strategy of combining a strong product with ecosystem partnerships and patient edu...

Dr Reddy's Laboratories is set to launch generic semaglutide, a popular weight loss drug. An expert committee has approved their proposal. ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like Ozempic and Mounja...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participant...

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating habits. The stud...

Eli Lilly Weight Loss Drug: India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to ...

Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...

Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess ...